Literature DB >> 3706378

Tumor biology in explanation of the failure of screening for cancer and in determination of future strategies.

F J Meyers.   

Abstract

Screening examinations for so-called "early cancer" are popular methods to decrease cancer mortality. This report reviews current concepts in tumor biology that explain why screening for cancer succeeds and why it fails. From this review, three biologic subgroups emerge for many cancers. In only one of these groups will screening methods be successful in decreasing death from cancer. Breast cancer and prostatic cancer are specifically considered to support this hypothesis. Implications for future investigations and the impact on public policy are discussed.

Entities:  

Mesh:

Year:  1986        PMID: 3706378     DOI: 10.1016/0002-9343(86)90637-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

Review 1.  Screening for prostate cancer. Implications for drug therapy.

Authors:  R H Harwood
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

Review 2.  The pros and cons of fecal occult blood testing for colorectal neoplasms.

Authors:  J B Simon
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Screening for cancer. Is it worth it?

Authors:  F J Meyers
Journal:  West J Med       Date:  1995-08

Review 4.  Progress and problems in screening for carcinoma of the prostate.

Authors:  G W Chodak; H W Schoenberg
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.